Bone Metastases from Prostate Cancer 18F-Fluoride PET/CT in a Patient With Discordant Bone Scintigraphy and 11C-Choline PET/CT

被引：1

作者：

Garcia, Garzon, Jr. ^{[1
]}

Riera, Eduard ^{[1
]}

Valls, Eulalia ^{[1
]}

Soler, Marina ^{[1
]}

Bassa, Pere ^{[1
]}

Moragas, Merce ^{[1
]}

Lomena, Francisco ^{[1
]}

机构：

[1] Unidad PET TC CETIR ERESA, Barcelona 08950, Spain

来源：

CLINICAL NUCLEAR MEDICINE | 2013年 / 38卷 / 02期

关键词：

bone scintigraphy; C-11-choline PET/CT; F-18-fluoride PET/CT; prostate cancer; PSA elevation; bone metastases; BIOCHEMICAL RECURRENCE;

D O I：

10.1097/RLU.0b013e31827a20d3

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Bone scintigraphy has been used extensively in prostate cancer patients to detect bone involvement. C-11-choline PET/CT is indicated when a biochemical recurrence is suspected, as this procedure is able to detect local recurrence, lymph-node infiltration, and metastases. In cases where the results of these 2 procedures do not coincide, MRI is then usually performed. F-18-fluoride may become an alternative to MRI for bone imaging In our patient series, all bone lesions with C-11-choline uptake were metastases. F-18-Fluoride did not increase specificity of C-11-choline but increased sensitivity of bone scintigraphy. CT helped in the interpretation of osteoarthritis and trauma lesions.

引用

页码：120 / 124

页数：5

共 11 条

[1] Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET-CT:: a comparative study
Beheshti, Mohsen
Vali, Reza
Waldenberger, Peter
Fitz, Friedrich
Nader, Michael
Loidl, Wolfgang
Broinger, Gabriele
Stoiber, Franz
Foglman, Ignac
Langsteger, Werner
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (10) : 1766 - 1774
[2] The Use of F-18 Choline PET in the Assessment of Bone Metastases in Prostate Cancer: Correlation with Morphological Changes on CT
Beheshti, Mohsen
Vali, Reza
Waldenberger, Peter
Fitz, Friedrich
Nader, Michael
Hammer, Josef
Loidl, Wolfgang
Pirich, Christian
Fogelman, Ignac
Langsteger, Werner
[J]. MOLECULAR IMAGING AND BIOLOGY, 2009, 11 (06) : 446 - 454
[3] [18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse:: experience in 100 consecutive patients
Cimitan, Marino
Bortolus, Roberto
Morassut, Sandro
Canzonieri, Vincenzo
Garbeglio, Antonio
Baresic, Tanja
Borsatti, Eugenio
Drigo, Annalisa
Trovo, Mauro G.
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (12) : 1387 - 1398
[4] Even-Sapir E, 2006, J NUCL MED, V47, P287
[5] Even-Sapir E, 2005, J NUCL MED, V46, P1356
[6] Radionuclide bone scintigraphy in patients with biochemical recurrence after radical prostatectomy: when is it indicated?
Gomez, P
Manoharan, M
Kim, SS
Soloway, MS
[J]. BJU INTERNATIONAL, 2004, 94 (03) : 299 - 302
[7] Prospective Evaluation of 18F-NaF and 18F-FDG PET/CT in Detection of Occult Metastatic Disease in Biochemical Recurrence of Prostate Cancer
Jadvar, Hossein
Desai, Bhushan
Ji, Lingyun
Conti, Peter S.
Dorff, Tanya B.
Groshen, Susan G.
Gross, Mitchell E.
Pinski, Jacek K.
Quinn, David I.
[J]. CLINICAL NUCLEAR MEDICINE, 2012, 37 (07) : 637 - 643
[8] 18F-fluoride uptake in bone metastasis: morphologic and metabolic analysis on integrated PET/CT
Kawaguchi, Masashi
Tateishi, Ukihide
Shizukuishi, Kazuya
Suzuki, Akiko
Inoue, Tomio
[J]. ANNALS OF NUCLEAR MEDICINE, 2010, 24 (04) : 241 - 247
[9] Prostate Carcinoma: Diffusion-weighted Imaging as Potential Alternative to Conventional MR and 11C-Choline PET/CT for Detection of Bone Metastases
Luboldt, Wolfgang
Kuefer, Rainer
Blumstein, Norbert
Toussaint, Todd L.
Kluge, Alexander
Seemann, Marcus D.
Luboldt, Hans-Joachim
[J]. RADIOLOGY, 2008, 249 (03) : 1017 - 1025
[10] Schirrmeister H, 1999, J NUCL MED, V40, P1623

← 1 2 →